We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Filters applied:

Search Results

Showing 1-20 of 259 results
  1. Targeting inflammatory signaling in obsessive compulsive disorder: a promising approach

    Obsessive-compulsive disorder (OCD) is a neuropsychiatric disorder. Approximately, around 2% to 3% percent of the general population experience...

    Shvetank Bhatt, Kuttiappan Anitha, ... Kamal Dua in Metabolic Brain Disease
    Article 11 November 2023
  2. MMP-9 and TIMP-1 Levels in Children and Adolescents with Obsessive Compulsive Disorder

    Abstract

    This study aimed to evaluate matrix metalloproteinase-9(MMP-9), tissue inhibitors of matrix metalloproteinases (TIMP-1) and the ratio of...

    Selçuk Dalyan, Özge Gizli Çoban, ... Sadıka Halide Akbaş in Neurochemical Journal
    Article 01 March 2023
  3. Nutritional Deficiencies in Obsessive-Compulsive Disorder and Possible Treatment Interventions

    Obsessive-compulsive disorder (OCD) is a neuropsychiatric disorder characterized by intrusive distressing thoughts, images, or impulses (obsessions)...
    Pranshul Sethi, Sumit Kumar, ... Samer El Hayek in Nutrition and Psychiatric Disorders
    Chapter 2022
  4. Pharmacogenetics of Obsessive-Compulsive Disorder: An Evidence-Update

    Pharmacogenetics has become increasingly important in the treatment of psychiatric disorders because approximately 50% of individuals who take...
    Chapter 2021
  5. Inflammation, Obsessive-Compulsive Disorder, and Related Disorders

    Initial reports supporting the possibility of inflammation in the brain in obsessive-compulsive disorder (OCD) evolved from the models of Sydenham’s...
    Chapter 2021
  6. Innovations in the Delivery of Exposure and Response Prevention for Obsessive-Compulsive Disorder

    Obsessive-Compulsive Disorder is an important cause of global health-related disability. In the last several decades, exposure and response...
    Sapana R. Patel, Jonathan Comer, Helen Blair Simpson in The Neurobiology and Treatment of OCD: Accelerating Progress
    Chapter 2021
  7. Psilocybin for the Treatment of Obsessive-Compulsive Disorders

    Obsessive-compulsive disorder (OCD) is a highly prevalent and disabling condition for which currently available treatments are insufficiently...
    Katja Ehrmann, John J. B. Allen, Francisco A. Moreno in Disruptive Psychopharmacology
    Chapter 2021
  8. SSRIs in the Treatment of Depression: A Pharmacological CUL-DE-SAC?

    The widespread adoption of selective serotonin reuptake inhibitors (SSRIs) as first-line pharmacological treatments in the management of clinical...
    Chapter 2023
  9. Clozapine generates obsessive compulsive disorder-like behavior in mice

    Clozapine is thought to induce obsessive compulsive symptoms (OCS) in schizophrenic patients. However, because OCS are often comorbid with...

    Shinwon Kang, Hyun Jong Noh, ... Chul Hoon Kim in Molecular Brain
    Article Open access 29 May 2020
  10. Glutamate Function in Anxiety Disorders and OCD: Evidence from Clinical and Translational Studies

    Anxiety disorders affect a significant number of the world population. They are among the most prevalent disorders in society and impose enormous...
    Tália Cássia Boff, Silvio José Batista Soares, ... Zuleide Maria Ignácio in Glutamate and Neuropsychiatric Disorders
    Chapter 2022
  11. Enhancing Fear Extinction: Pharmacological Approaches

    Extinction is the process by which the memory of a learned conditioned association decreases over time and with introduction of new associations. It...
    Olga Y. Ponomareva, Robert J. Fenster, Kerry J. Ressler in Fear Extinction
    Chapter 2023
  12. Central norepinephrine transmission is required for stress-induced repetitive behavior in two rodent models of obsessive-compulsive disorder

    Rationale

    Obsessive-compulsive disorder (OCD) is characterized by repetitive behaviors exacerbated by stress. Many OCD patients do not respond to...

    Daniel Lustberg, Alexa F. Iannitelli, ... David Weinshenker in Psychopharmacology
    Article 20 April 2020
  13. Anti-Inflammatory Therapy as a Promising Target in Neuropsychiatric Disorders

    This chapter analyzes the therapeutic potential of current anti-inflammatory drugs in treating psychiatric diseases from a neuro-immunological...
    Chapter 2023
  14. St. Johnʼs wort (Hypericum perforatum) and depression: what happens to the neurotransmitter systems?

    St. Johnʼs wort ( Hypericum perforatum ) is a herbaceous plant containing many bioactive molecules including naphthodianthrones, phloroglucinol...

    Gita Kholghi, Shirin Arjmandi-Rad, ... Salar Vaseghi in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 16 March 2022
  15. Pharmacotherapeutic Strategies and New Targets in OCD

    Effective pharmacological and psychotherapeutic treatments are well established for obsessive-compulsive disorder (OCD). Serotonin reuptake...
    Chapter 2021
  16. Cannabidiol for the treatment of autism spectrum disorder: hope or hype?

    Rationale

    Autism spectrum disorder (ASD) is defined as a group of neurodevelopmental disorders whose symptoms include impaired communication and...

    João F. C. Pedrazzi, Frederico R. Ferreira, ... José A. S. Crippa in Psychopharmacology
    Article 29 July 2022
  17. The Role of the Glutamate System in Posttraumatic Stress Disorder and Glutamate-Based Treatments

    Posttraumatic Stress Disorder (PTSD) is a chronic mental illness with limited options for treatment, characterized by intrusive memory of trauma,...
    M. Popoli, A. Ieraci, L. Musazzi in Glutamate and Neuropsychiatric Disorders
    Chapter 2022
  18. Psychedelic treatments for mental health conditions pose challenges for informed consent

    Carolina Seybert, Gonçalo Cotovio, ... Albino J. Oliveira-Maia in Nature Medicine
    Article 14 June 2023
  19. Drugs Acting on Central Nervous System

    Central nervous system is the part of the body which is responsible for accepting, processing, and creating response against the external stimuli or...
    Dipesh Chakraborty, Ria Das in Essentials of Pharmacodynamics and Drug Action
    Chapter 2024
  20. Pharmacotherapy of Depression and Anxiety Disorders

    Depression and anxiety are mental disorders that are difficult to diagnose and even more difficult to treat. While pharmacotherapy is one strong...
    Sadhana N. Holla, Avinash Arivazhahan in Introduction to Basics of Pharmacology and Toxicology
    Chapter 2021
Did you find what you were looking for? Share feedback.